Glenmark Life Sciences Future Growth

How is Glenmark Life Sciences forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

15.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

BSE:543322 - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2025	26,383	5,686	3,708	5,017	3
3/31/2024	23,212	4,709	2,176	4,393	4
3/31/2023	20,402	4,041	2,847	5,015	4
9/30/2022	20,357	4,182	1,991	3,856	N/A
6/30/2022	20,882	4,265	N/A	N/A	N/A
3/31/2022	21,232	4,187	4,654	5,976	N/A
12/31/2021	20,763	4,245	N/A	N/A	N/A
9/30/2021	20,541	4,142	4,443	5,291	N/A
6/30/2021	20,131	3,714	N/A	N/A	N/A
3/31/2021	18,852	3,516	3,201	3,881	N/A
3/31/2020	15,373	3,131	1,438	1,950	N/A
3/31/2019	8,864	1,956	10	104	N/A
3/31/2018	2	-4	-5	-5	N/A

Earnings vs Savings Rate: 543322's forecast earnings growth (15% per year) is above the savings rate (6.8%).

Earnings vs Market: 543322's earnings (15% per year) are forecast to grow slower than the Indian market (19.8% per year).

High Growth Earnings: 543322's earnings are forecast to grow, but not significantly.

Revenue vs Market: 543322's revenue (12.2% per year) is forecast to grow faster than the Indian market (10.6% per year).

High Growth Revenue: 543322's revenue (12.2% per year) is forecast to grow slower than 20% per year.

Future ROE: 543322's Return on Equity is forecast to be high in 3 years time (20.1%)